Iridex (IRIX) Latest Stock Analysis Report β Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $0.82, +0.00% vs the prior close of $0.82.
- Volume 165.00K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IRIX ends flat (+0.0%) to $0.82, 3 down days in a row. Closed at $0.82, +0.00% vs the prior close of $0.82. Day range $0.77β$0.90, opened at $0.79.
IRIX daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 β IRIX ends flat (+0.0%) to $0.82, 3 down days in a row
- Closed at $0.82, +0.00% vs the prior close of $0.82. Day range $0.77β$0.90, opened at $0.79.
- Volume was 165.00K shares, 0.3x its 50-day average of 490.63K β lighter than usual.
- Price is +11.1% vs its 50-day average ($0.74) and -23.1% vs its 200-day average ($1.07).
- 52-week range $0.61β$1.65; today's close sits at 20% of that range, 50.3% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 β IRIX slides 3.5% to $0.82
- Closed at $0.82, -3.53% vs the prior close of $0.85. Day range $0.78β$0.85, opened at $0.83.
- Volume was 34.10K shares, 0.1x its 50-day average of 490.97K β lighter than usual.
- Price is +11.0% vs its 50-day average ($0.74) and -23.2% vs its 200-day average ($1.07).
- 52-week range $0.61β$1.65; today's close sits at 20% of that range, 50.3% below the 52-week high.
Oct 13, 2026 β IRIX slides 8.6% to $0.85
- Closed at $0.85, -8.60% vs the prior close of $0.93. Day range $0.82β$0.95, opened at $0.95.
- Volume was 185.50K shares, 0.4x its 50-day average of 489.63K β lighter than usual.
- Price is +15.1% vs its 50-day average ($0.74) and -20.5% vs its 200-day average ($1.07).
- 52-week range $0.61β$1.65; today's close sits at 23% of that range, 48.5% below the 52-week high.
Oct 12, 2026 β IRIX jumps 4.5% to $0.93, a 1-month high
- Closed at $0.93, +4.49% vs the prior close of $0.89. Day range $0.84β$0.98, opened at $0.88.
- Volume was 292.50K shares, 0.6x its 50-day average of 485.52K.
- Price is +25.9% vs its 50-day average ($0.74) and -13.2% vs its 200-day average ($1.07).
- 52-week range $0.61β$1.65; today's close sits at 31% of that range, 43.6% below the 52-week high.
Oct 9, 2026 β IRIX dips 1.1% to $0.89
- Closed at $0.89, -1.11% vs the prior close of $0.90. Day range $0.81β$0.92, opened at $0.92.
- Volume was 202.40K shares, 0.4x its 50-day average of 483.53K β lighter than usual.
- Price is +20.9% vs its 50-day average ($0.74) and -17.0% vs its 200-day average ($1.07).
- 52-week range $0.61β$1.65; today's close sits at 27% of that range, 46.1% below the 52-week high.
Oct 8, 2026 β IRIX rises 2.3% to $0.90, a 1-month high
- Closed at $0.90, +2.27% vs the prior close of $0.88. Day range $0.79β$0.95, opened at $0.83.
- Volume was 706.20K shares, 1.5x its 50-day average of 470.33K.
- Price is +22.4% vs its 50-day average ($0.73) and -16.1% vs its 200-day average ($1.07).
- 52-week range $0.61β$1.65; today's close sits at 28% of that range, 45.5% below the 52-week high.
Oct 7, 2026 β IRIX jumps 29.4% to $0.88, a 1-month high on 262.1x normal volume
- Closed at $0.88, +29.41% vs the prior close of $0.68. Day range $0.66β$1.02, opened at $0.69.
- Volume was 19.76M shares, 262.1x its 50-day average of 75.39K β unusually heavy trading.
- Price is +19.9% vs its 50-day average ($0.73) and -18.0% vs its 200-day average ($1.07).
- 52-week range $0.61β$1.65; today's close sits at 26% of that range, 46.7% below the 52-week high.
Oct 6, 2026 β IRIX dips 1.4% to $0.68
- Closed at $0.68, -1.45% vs the prior close of $0.69. Day range $0.68β$0.73, opened at $0.72.
- Volume was 28.20K shares, 0.4x its 50-day average of 75.47K β lighter than usual.
- Price is -7.4% vs its 50-day average ($0.73) and -36.7% vs its 200-day average ($1.07).
- 52-week range $0.61β$1.65; today's close sits at 7% of that range, 58.8% below the 52-week high.
Oct 5, 2026 β IRIX jumps 7.8% to $0.69 on 1.9x normal volume
- Closed at $0.69, +7.81% vs the prior close of $0.64. Day range $0.65β$0.74, opened at $0.65.
- Volume was 136.40K shares, 1.9x its 50-day average of 73.36K β unusually heavy trading.
- Price is -6.6% vs its 50-day average ($0.74) and -35.8% vs its 200-day average ($1.08).
- 52-week range $0.61β$1.65; today's close sits at 8% of that range, 58.2% below the 52-week high.
Oct 2, 2026 β IRIX rises 1.6% to $0.64
- Closed at $0.64, +1.59% vs the prior close of $0.63. Day range $0.62β$0.65, opened at $0.62.
- Volume was 24.30K shares, 0.3x its 50-day average of 73.40K β lighter than usual.
- Price is -13.8% vs its 50-day average ($0.74) and -40.6% vs its 200-day average ($1.08).
- 52-week range $0.61β$1.65; today's close sits at 3% of that range, 61.2% below the 52-week high.
IRIX latest news & SEC filings
Every SEC filing by or about IRIX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Novel Inspiration International Co., Ltd. & Lin Shih-Yao David reported an other transaction of 146,313 shares on Oct 2, 2026; now holds 697,742
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Lin Shih-Yao David bought 244 shares at $0.93 (β$227) on Dec 3, 2025; now holds 836,496
- Lin Shih-Yao David bought 10,260 shares at $0.94 (β$9.64K) on Dec 5, 2025; now holds 846,756
- Lin Shih-Yao David bought 20,000 shares at $0.94 (β$18.80K) on Dec 9, 2025; now holds 866,756
- Lin Shih-Yao David bought 18,892 shares at $0.94 (β$17.66K) on Dec 10, 2025; now holds 885,648
- Lin Shih-Yao David bought 20,000 shares at $0.97 (β$19.40K) on Dec 12, 2025; now holds 905,648
- Lin Shih-Yao David bought 11,404 shares at $0.94 (β$10.72K) on Dec 15, 2025; now holds 917,052
- β¦plus 24 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Lin Shih-Yao David bought 18,161 shares at $0.97 (β$17.62K) on Jun 6, 2025; now holds 588,345
- Lin Shih-Yao David bought 15,755 shares at $0.99 (β$15.53K) on Jun 9, 2025; now holds 604,100
- Lin Shih-Yao David bought 236 shares at $0.94 (β$222) on Jun 12, 2025; now holds 604,336
- Lin Shih-Yao David bought 1,582 shares at $0.94 (β$1.49K) on Jun 13, 2025; now holds 605,918
- Lin Shih-Yao David bought 14,712 shares at $0.94 (β$13.83K) on Jun 16, 2025; now holds 620,630
- Lin Shih-Yao David bought 101 shares at $0.96 (β$97) on Jun 17, 2025; now holds 620,731
- β¦plus 24 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 7, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Lin Shih-Yao David bought 5,000 shares at $0.93 (β$4.67K) on Mar 25, 2025; now holds 5,000
- Lin Shih-Yao David bought 8,834 shares at $0.89 (β$7.88K) on Mar 26, 2025; now holds 13,834
- Lin Shih-Yao David bought 15,000 shares at $0.89 (β$13.35K) on Apr 4, 2025; now holds 28,834
- Lin Shih-Yao David bought 10,674 shares at $0.84 (β$8.96K) on Apr 7, 2025; now holds 39,508
- Lin Shih-Yao David bought 2,995 shares at $0.85 (β$2.55K) on Apr 8, 2025; now holds 42,503
- Lin Shih-Yao David bought 6,226 shares at $0.87 (β$5.42K) on Apr 9, 2025; now holds 48,729
- β¦plus 24 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Mercer Patrick had withheld for taxes 23,917 shares at $0.63 (β$15.12K) on Oct 1, 2026; now holds 444,867
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Dizon Romeo R bought 7,900 shares at $0.63 (β$4.98K) on Sep 16, 2026; now holds 185,306
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 2, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.01 β Stock exchange listing notice or transfer of listing.
Aug 18, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jul 4, 2026:
- Revenue: $12.57M (prior year $13.57M) (-7.4% vs Jun 28, 2025)
- Net income: -$1.27M (prior year -$994.00K) (loss widened vs Jun 28, 2025)
- Diluted EPS: -$0.07 (prior year -$0.06) (loss widened vs Jun 28, 2025)
Aug 18, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 16, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.07 β Reported shareholder vote results.
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Jul 13, 2026 Β· Form SCHEDULE 13D/A β Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 18, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Things to know before you trade IRIX
- Last results release: Aug 18, 2026 (8-K Item 2.02). Previous ones: May 19, 2026, Mar 26, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 17, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.79% (largest 29.4%). That is a volatile stock.
- Liquidity: about 1.10M shares (β$897.97K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.82 vs a range of $0.61β$1.65 (20% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Romeo R Dizon bought 7,900 shares on Sep 16, 2026.
- Latest filings: 8-K Sep 2, 2026; 10-Q Aug 18, 2026; 8-K Aug 18, 2026.
- Share count: 17.56M shares outstanding (Aug 13, 2026), +3.4% vs a year earlier.
- Listing: Nasdaq Β· industry: Electromedical & Electrotherapeutic Apparatus.
IRIX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 0.79 | 0.90 | 0.77 | 0.82 | 165.00K |
| Oct 14, 2026 | 0.83 | 0.85 | 0.78 | 0.82 | 34.10K |
| Oct 13, 2026 | 0.95 | 0.95 | 0.82 | 0.85 | 185.50K |
| Oct 12, 2026 | 0.88 | 0.98 | 0.84 | 0.93 | 292.50K |
| Oct 9, 2026 | 0.92 | 0.92 | 0.81 | 0.89 | 202.40K |
| Oct 8, 2026 | 0.83 | 0.95 | 0.79 | 0.90 | 706.20K |
| Oct 7, 2026 | 0.69 | 1.02 | 0.66 | 0.88 | 19.76M |
| Oct 6, 2026 | 0.72 | 0.73 | 0.68 | 0.68 | 28.20K |
| Oct 5, 2026 | 0.65 | 0.74 | 0.65 | 0.69 | 136.40K |
| Oct 2, 2026 | 0.62 | 0.65 | 0.62 | 0.64 | 24.30K |
| Oct 1, 2026 | 0.62 | 0.64 | 0.62 | 0.63 | 65.50K |
| Sep 30, 2026 | 0.62 | 0.64 | 0.62 | 0.63 | 23.00K |
| Sep 29, 2026 | 0.62 | 0.65 | 0.62 | 0.64 | 45.00K |
| Sep 28, 2026 | 0.64 | 0.64 | 0.62 | 0.62 | 23.20K |
| Sep 25, 2026 | 0.63 | 0.65 | 0.62 | 0.63 | 27.80K |
| Sep 24, 2026 | 0.63 | 0.65 | 0.63 | 0.63 | 34.80K |
| Sep 23, 2026 | 0.64 | 0.65 | 0.63 | 0.63 | 17.50K |
| Sep 22, 2026 | 0.67 | 0.67 | 0.64 | 0.64 | 12.10K |
| Sep 21, 2026 | 0.66 | 0.67 | 0.64 | 0.64 | 46.10K |
| Sep 18, 2026 | 0.64 | 0.67 | 0.64 | 0.67 | 75.40K |
About Iridex
Iridex (IRIX) is listed on the Nasdaq and classified by the SEC under βElectromedical & Electrotherapeutic Apparatusβ. Its business address is in MOUNTAIN VIEW, CA. State of incorporation: DE. Fiscal year ends January 3. SEC CIK 1006045.
IRIX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| William M Moore | Director | Dec 18, 2025 |
| Patrick Mercer | President and CEO | Jul 14, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Romeo R Dizon | Chief Financial Officer | Sep 16, 2026 |
| Patrick Mercer | President and CEO | Jul 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 16, 2026 | Romeo R Dizon | Buy | 7,900 | $0.63 |
| Sep 14, 2026 | Romeo R Dizon | Buy | 2,354 | $0.65 |
| Sep 10, 2026 | Romeo R Dizon | Buy | 5,100 | $0.68 |
| Aug 24, 2026 | Romeo R Dizon | Buy | 1,300 | $0.75 |
| Aug 24, 2026 | Romeo R Dizon | Buy | 5,368 | $0.75 |
| Jun 12, 2026 | Romeo R Dizon | Buy | 975 | $1.14 |
| Jun 11, 2026 | Romeo R Dizon | Buy | 1,675 | $1.14 |
| Jun 8, 2026 | Romeo R Dizon | Buy | 2,400 | $1.12 |
| Jun 5, 2026 | Romeo R Dizon | Buy | 2,521 | $1.15 |
| Jun 3, 2026 | Romeo R Dizon | Buy | 2,400 | $1.17 |
| May 26, 2026 | Romeo R Dizon | Buy | 5,004 | $1.00 |
| Mar 6, 2026 | Romeo R Dizon | Buy | 1,110 | $1.26 |
| Feb 17, 2026 | Romeo R Dizon | Buy | 1,200 | $1.31 |
| Feb 17, 2026 | Romeo R Dizon | Buy | 1,000 | $1.37 |
| Feb 12, 2026 | Romeo R Dizon | Buy | 1,500 | $1.43 |
IRIX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Jan 3, 2026 | $52.67M | $-4.44M | -0.26 | $-2.12M |
| Dec 28, 2024 | $48.67M | $-8.91M | -0.54 | $-7.29M |
| Dec 30, 2023 | $51.87M | $-9.57M | -0.59 | $-6.75M |
| Dec 31, 2022 | $56.97M | $-7.55M | -0.47 | $-9.52M |
| Jan 1, 2022 | $53.90M | $-5.22M | -0.34 | $8.22M |
Latest balance sheet: total assets $27.26M, total liabilities $23.62M, cash $4.68M (as of Jul 4, 2026).
IRIX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 18, 2026 | 8-K Item 2.02 (results) | $0.93 |
| May 19, 2026 | 8-K Item 2.02 (results) | $1.05 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $1.35 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $1.48 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $0.95 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $1.30 |
| May 13, 2025 | 8-K Item 2.02 (results) | $1.10 |
| Apr 14, 2025 | 8-K Item 2.02 (results) | $0.99 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $0.88 |
| Jan 14, 2025 | 8-K Item 2.02 (results) | $1.61 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $1.41 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)TransMedics (TMDX)Integer (ITGR)LivaNova (LIVN)Axogen (AXGN)Ceribell (CBLL)Conmed (CNMD)InMode (INMD)Neuraxis (NRXS)Electromed (ELMD)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on IRIX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.